News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
n-Lorem and EspeRare announce European collaboration to expand access to individualized ASO Therapies for Rare Genetic Diseases
n-Lorem and EspeRare collaborate to expand access to individualized ASO Therapies for Rare Genetic Diseases in Europe, focusing on Switzerland and EU, to develop regulatory and clinical pathways -
COMMUNIQUÉ DE PRESSE
Polaris Renewable Energy Announces Q4 and Annual 2025 Investor Call Details
Polaris Renewable Energy Inc. to hold Q4 and 2025 annual earnings conference call and webcast on February 19th, 2026, at 10:00 am EST. Company focused on renewable energy projects in Latin America and the Caribbean -
-
-
COMMUNIQUÉ DE PRESSE
Worksport Provides 2026 Business Update: Clean Energy Products Shipping Now, OEM and Major Distribution Conversations Deepen, Record Growth Forecasted
Worksport provides 2026 corporate update with SOLIS solar systems shipping, B2B expansion, EV OEM discussions, and Aetherlux updates. CEO anticipates significant growth year -
COMMUNIQUÉ DE PRESSE
NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza Wave - NV-387 is Effective Against H3N2
NanoViricides, Inc. declares need for broad-spectrum antivirals amid severe influenza epidemic, highlighting potential of NV-387 against multiple viruses
